Aflac Incorporated (NYSE:AFL) Shares Bought by Fidelis Capital Partners LLC

Fidelis Capital Partners LLC increased its holdings in Aflac Incorporated (NYSE:AFL) by 12.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,634 shares of the financial services provider’s stock after buying an additional 530 shares during the quarter. Fidelis Capital Partners LLC’s holdings in Aflac were worth $382,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Fortitude Family Office LLC acquired a new stake in shares of Aflac during the 4th quarter worth approximately $25,000. CoreFirst Bank & Trust acquired a new stake in Aflac in the 4th quarter valued at $25,000. Studio Investment Management LLC purchased a new position in Aflac in the 4th quarter valued at $27,000. Impact Partnership Wealth LLC lifted its holdings in Aflac by 471.4% in the 3rd quarter. Impact Partnership Wealth LLC now owns 400 shares of the financial services provider’s stock valued at $31,000 after purchasing an additional 330 shares in the last quarter. Finally, Bruce G. Allen Investments LLC purchased a new position in Aflac in the 4th quarter valued at $32,000. Institutional investors and hedge funds own 67.44% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. StockNews.com lowered Aflac from a “hold” rating to a “sell” rating in a report on Wednesday, April 10th. UBS Group lifted their price target on Aflac from $80.00 to $84.00 and gave the stock a “neutral” rating in a report on Wednesday, January 10th. Piper Sandler lifted their price target on Aflac from $90.00 to $95.00 and gave the stock an “overweight” rating in a report on Friday, April 5th. Raymond James lifted their price target on Aflac from $83.00 to $88.00 and gave the stock an “outperform” rating in a report on Friday, February 2nd. Finally, Morgan Stanley lifted their price target on Aflac from $80.00 to $84.00 and gave the stock an “equal weight” rating in a report on Monday, April 15th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $82.15.

Insider Buying and Selling at Aflac

In other news, Director Thomas J. Kenny sold 5,000 shares of the business’s stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $84.62, for a total transaction of $423,100.00. Following the completion of the transaction, the director now directly owns 17,920 shares of the company’s stock, valued at $1,516,390.40. The sale was disclosed in a filing with the SEC, which is accessible through this link. In other news, Director Thomas J. Kenny sold 5,000 shares of the business’s stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $84.62, for a total transaction of $423,100.00. Following the completion of the transaction, the director now directly owns 17,920 shares of the company’s stock, valued at $1,516,390.40. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Arthur Reginald Collins sold 3,000 shares of the business’s stock in a transaction that occurred on Thursday, February 22nd. The stock was sold at an average price of $79.73, for a total value of $239,190.00. Following the sale, the director now owns 5,592 shares of the company’s stock, valued at approximately $445,850.16. The disclosure for this sale can be found here. Insiders sold a total of 46,493 shares of company stock valued at $3,765,706 in the last three months. 0.90% of the stock is owned by corporate insiders.

Aflac Stock Performance

NYSE AFL opened at $83.23 on Friday. The company has a market cap of $47.89 billion, a P/E ratio of 10.74, a P/E/G ratio of 2.20 and a beta of 0.91. The company has a debt-to-equity ratio of 0.33, a current ratio of 0.06 and a quick ratio of 0.06. The stock has a 50-day moving average of $82.21 and a two-hundred day moving average of $81.50. Aflac Incorporated has a 1-year low of $64.10 and a 1-year high of $86.26.

Aflac (NYSE:AFL) last released its earnings results on Thursday, February 1st. The financial services provider reported $1.25 earnings per share for the quarter, missing the consensus estimate of $1.47 by ($0.22). The firm had revenue of $3.78 billion during the quarter, compared to analyst estimates of $4.44 billion. Aflac had a net margin of 24.92% and a return on equity of 17.59%. During the same period in the prior year, the firm earned $1.29 earnings per share. As a group, analysts anticipate that Aflac Incorporated will post 6.41 EPS for the current year.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.